Comparative effectiveness of finerenone versus steroidal mineralocorticoid receptor antagonists on sepsis-induced cardiomyopathy in patients with diabetic kidney disease: a real-world cohort study

Jheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, Hsuan-Yuan Chang, Yu-Min Lin · 2026

Read Comparative effectiveness of finerenone versus steroidal mineralocorticoid receptor antagonists on sepsis-induced cardiomyopathy in patients with diabetic kidney disease: a real-world cohort study by Jheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, Hsuan-Yuan Chang, Yu-Min Lin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13457483.txt.

Description

Jheng-Yan Wu and colleagues compare two hormone-blocking drug families in diabetic kidney disease patients with sepsis-related heart weakness. Mineralocorticoid receptor activation may worsen the cardiac slump of sepsis, and the non-steroidal blocker finerenone was untested against older steroidal rivals for this complication. Their 2026 study used the TriNetX health record network to build matched groups of 1,378 patients each. One group started finerenone and the other a steroidal agent, during sepsis episodes from 2021 to 2025.

Heart failure-type complications struck 3.3 percent of the finerenone group against 5.2 percent of the steroidal group, a hazard ratio of 0.59. All-cause death was less frequent too, at a hazard ratio of 0.45, and markers of heart muscle injury favored finerenone. The pattern held across subgroups, weakening only among patients not on SGLT2 inhibitors. The authors urge caution: record-based comparisons can hide bias, so these results are hypothesis-generating and need prospective trials.

Catalog record

CREATORJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, Hsuan-Yuan Chang, Yu-Min Lin
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13457483

Browse the full library · About the Tower of Babel